Researchers have found a new way to reactivate fetal hemoglobin without the need for gene-editing therapy, according to a new study.
Disc Medicine will be enrolling 24 adults with SCD in its newly launched trial testing DISC-3405 at three doses for easing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback